Geneos Wealth Management’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History
Bought
Maintained
Sold
Other funds holding IBDS
HPC
SVWAG
CIA
Geneos Wealth Management's IBDS Position: Q2 2026 in Review
Geneos Wealth Management held its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) position steady in Q2 2026 at 9,620 shares worth $233K. The position accounts for ﹤0.01% of the portfolio, ranked #941.
Geneos Wealth Management first reported a position in IBDS in Q3 2019 and has held it in 28 quarters since. The position peaked at $234K in Q3 2025. 416 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.
- Geneos Wealth Management held 9,620 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $233K as of Q2 2026.
- Geneos Wealth Management left its iShares iBonds Dec 2027 Term Corporate ETF share count unchanged in Q2 2026.
- iShares iBonds Dec 2027 Term Corporate ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #941 holding.
- Geneos Wealth Management first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q3 2019 and has held it in 28 quarters since.
- Geneos Wealth Management's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $234K in Q3 2025.
- 416 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.
Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.